A new tool that helps surgeons distinguish healthy tissue from tumor in real-time could change the landscape of surgical ovarian cancer treatment for the better.
Cancer is never an easy foe, but some types are more stubborn than others. Ovarian cancer is one of the hardest to treat… but there are signs of progress.
The Colorado Center for Gynecologic Oncology is excited to share our September Newsletter providing patients with new information, upcoming events and inspiring stories.
September is Gynecologic Cancer Awareness Month (GCAM). The Foundation for Women’s Cancer (FWC) knows the importance of bringing awareness to gynecologic cancers. After creating the month, each year the FWC strives to bring attention and share information about these cancers.
Scientists at Winship Cancer Institute of Emory University have identified an enzyme responsible for making tumors and cancer cell lines resistant to cisplatin, along with an experimental drug that targets that enzyme.
Adults with diabetes have a 10% greater risk for developing any cancer vs. those without diabetes, whereas the disease confers a greater risk for overall and certain site-specific cancers in women vs. men, according to findings from a meta-analysis published in Diabetologia.
While extended adjuvant tamoxifen therapy has been found to improve breast cancer-free survival rates in premenopausal women with estrogen-receptor positive breast cancer, new research suggests that may not be without risk…
The Colorado Center for Gynecologic Oncology is excited to share our August Newsletter providing patients with new information, upcoming events and inspiring stories.
It is a strange notion that it can take one moment to shift one’s perspective. We spend a lot of time studying what is wrong in the world around us. We ask why me? Why is this happening? Perhaps another potential question to ask is…why not me?
Vaccination against the human papillomavirus (HPV) is highly protective against precancerous cervical lesions in adolescents and young women compared with placebo, especially those who are negative for HPV at the time of vaccination, a systematic Cochrane review concludes.